shutterstock_1764329549_ben_photo

Ben Photo / Shutterstock.com

23 June 2021BiotechnologyThe C5 Group (American Conference Institute, The Canadian Institute, C5)

Conference preview: ACI breaks down Section 337 at the 13th Annual Practitioners’ Think Tank

The C5 Group—which constitutes the ACI, The Canadian Institute and C5—invites WIPR readers to the conference on July 27-28, 2021, to find out exactly how these new developments will impact their practice and clients.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

‘Breaking’ patents would harm innovation: think tank

5 March 2019 The Information Technology and Innovation Foundation think tank has called on the US National Institutions of Health to maintain IP protection amid calls to “break” patents in order to lower drug prices.

Biosimilar boom could save billions, think tank claims

25 October 2017 Introducing more biosimilars could cut healthcare spending by $54 billion over the next ten years, a figure far higher than initially thought, a think tank and research organisation has claimed.

More on this story

‘Breaking’ patents would harm innovation: think tank

5 March 2019 The Information Technology and Innovation Foundation think tank has called on the US National Institutions of Health to maintain IP protection amid calls to “break” patents in order to lower drug prices.

Biosimilar boom could save billions, think tank claims

25 October 2017 Introducing more biosimilars could cut healthcare spending by $54 billion over the next ten years, a figure far higher than initially thought, a think tank and research organisation has claimed.

More on this story

‘Breaking’ patents would harm innovation: think tank

5 March 2019 The Information Technology and Innovation Foundation think tank has called on the US National Institutions of Health to maintain IP protection amid calls to “break” patents in order to lower drug prices.

Biosimilar boom could save billions, think tank claims

25 October 2017 Introducing more biosimilars could cut healthcare spending by $54 billion over the next ten years, a figure far higher than initially thought, a think tank and research organisation has claimed.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

ResMed voids sleep apnoea tech patent at PTAB

Novartis settles with licensee of blood cancer therapy day before trial

Biotech and healthcare expert returns to Latham & Watkins

Commercialising genomic tech in Nigeria

Medical company sees $452m trade secrets award cut by 87%

Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO

Strategic IP protection for biotech-related GenAI